In the 5×FAD mouse model, temporary depletion of Foxp3+ Tregs has been shown to alleviate AD pathology, indicating that Treg-mediated systemic immune suppression may play a negative role in AD pathology [2]. This evidence concerns the gene FOXP3 and Alzheimer disease.